Exchange Announcement • 29 Sep 2026 08:00
Voluntary Announcement - Hutchmed Announces Submission Of Us Nda For Orpathys Plus Tagrisso In Met Driven Egfr-Mutated Lung Cancer
Exchange Announcement • 28 Sep 2026 08:00
Voluntary Announcement - Hutchmed Initiates Global Trial Of Kras-Egfr-Antibody Conjugate Therapy Hmpl-A830 In Patients With Solid Tumors
Exchange Announcement • 24 Sep 2026 08:00
Voluntary Announcement - Hutchmed Highlights Clinical Data To Be Presented At The Esmo Congress 2026
Exchange Announcement • 03 Sep 2026 12:01
Hutchmed Announces Licensing Agreement With Gsk For Kras-Egfr-Antibody Conjugate Cancer Therapy
Exchange Announcement • 31 Aug 2026 08:00
